Suppr超能文献

锁骨下静脉用力性血栓形成混合治疗方法的单中心经验

Single-center experience in hybrid approach for subclavian vein effort thrombosis.

作者信息

Katelenets Maksym, Ginzburg Victor, Leytzin Anatoly, Shepovalov Dmitry, Nahel Abu Kush, Greenberg George

机构信息

Department of Vascular Surgery, Soroka Medical Center, Be'er-Sheva, Israel.

出版信息

J Vasc Surg Cases Innov Tech. 2025 Apr 9;11(4):101797. doi: 10.1016/j.jvscit.2025.101797. eCollection 2025 Aug.

Abstract

OBJECTIVE

Effort thrombosis of the subclavian vein (SCV) is one of the forms of deep vein thrombosis in the upper extremity and plays the leading role in venous thoracic outlet syndrome. This condition affects predominantly young and active people and can lead to extremity functional deterioration and long-term consequences. Despite the apparent clinical importance, no consensus or accepted protocol regarding optimal treatment exists. The main aim of this study was to present our local treatment protocol and to assess its effectiveness, safety, and functional impact.

METHODS

We conducted a single-center retrospective analysis of 27 patients hospitalized and treated in our department with effort SCV thrombosis from September 2005 to December 2022. The median length of follow-up was 92 months (range, 6-140 months). Evaluation of early and late stent patency and the assessment of chronic venous insufficiency, using the Villalta score and arm functional status using the QuickDASH-9 questionnaire, were performed.

RESULTS

Of these 27 patients, 23 were treated using catheter-directed thrombolysis, first rib resection with subsequent endovascular repair of the SCV using a self-expanding stent. A total of 18 patients were assessed for vein patency and showed an early patency of 94.4% and a late patency of 83.3%. Four stents were found to be occluded. None of the treated patients has developed clinically significant chronic venous insufficiency, and the median Villalta score was 1 point. The median functional status of the arm measured by the QuickDASH-9 questionnaire was 2.75.

CONCLUSIONS

First rib resection is an integral part of the treatment approach and is prominent in releasing chronic bony compression of the SCV. Subsequent endovascular repair achieves unaffected prograde flow and excellent long-term vein patency. Despite surgical aggressiveness, the current approach shows promising results in the context of the safety and functional status of the affected limb.

摘要

目的

锁骨下静脉(SCV)用力性血栓形成是上肢深静脉血栓形成的一种形式,在胸廓出口综合征中起主要作用。这种情况主要影响年轻且活跃的人群,并可导致肢体功能恶化和长期后果。尽管在临床方面具有明显重要性,但关于最佳治疗方法尚无共识或公认的方案。本研究的主要目的是介绍我们的局部治疗方案,并评估其有效性、安全性和功能影响。

方法

我们对2005年9月至2022年12月在我科住院并接受治疗的27例用力性SCV血栓形成患者进行了单中心回顾性分析。中位随访时间为92个月(范围6 - 140个月)。使用Villalta评分评估早期和晚期支架通畅情况以及慢性静脉功能不全,并使用QuickDASH - 9问卷评估手臂功能状态。

结果

在这27例患者中,23例采用导管定向溶栓治疗,先行第一肋切除,随后使用自膨式支架对SCV进行血管内修复。共有18例患者接受了静脉通畅性评估,早期通畅率为94.4%,晚期通畅率为83.3%。发现4个支架闭塞。所有接受治疗的患者均未出现具有临床意义的慢性静脉功能不全,Villalta评分中位数为1分。通过QuickDASH - 9问卷测量的手臂中位功能状态为2.75。

结论

第一肋切除是治疗方法的一个组成部分,在解除SCV的慢性骨性压迫方面具有重要作用。随后的血管内修复可实现不受影响的顺行血流和出色的长期静脉通畅。尽管手术具有侵袭性,但在受影响肢体的安全性和功能状态方面,当前方法显示出令人鼓舞的结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73be/12141902/3210965b381f/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验